MAPT and Alzheimer disease: While the molecular cascades leading to synapse degeneration in AD have yet to be fully determined, there is ample evidence from both human brain and disease models supporting synaptotoxic roles of soluble pathological forms of Aβ and tau, as well as glial-mediated neuroinflammation (see [14] for an excellent recent meta-analysis).